Very Low-Dose Recombinant Activated Factor VIIa: A Paradigm Shift in Major Bleeding Therapy? - Assmann, A.; Albert, A.; Dierksen, A.; Roussel, E.; Sixt, S.; Lichtenberg, A.; Hoffmann, T. (The Thoracic and Cardiovascular Surgeon, 2017)